Collagen Q--a potential target for autoantibodies in myasthenia gravis. (Q54297679)

18 July 2018

title

Collagen Q--a potential target for autoantibodies in myasthenia gravis. (English)

1 reference

18 July 2018

0 references

1 reference

5

Angela Vincent

1 reference

18 July 2018

Marta Zoltowska Katarzyna

1

1 reference

18 July 2018

Katsiaryna Belaya

2

1 reference

18 July 2018

Maria Leite

3

1 reference

18 July 2018

Waters Patrick

4

1 reference

18 July 2018

David Beeson

6

1 reference

18 July 2018

publication date

18 December 2014

1 reference

18 July 2018

Journal of the Neurological Sciences

published in

1 reference

18 July 2018

volume

348

1 reference

18 July 2018

issue

1-2

1 reference

18 July 2018

page(s)

241-244

1 reference

18 July 2018

The search for new antigenic targets in myasthenia gravis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Detection of multiple antibodies in myasthenia gravis and its clinical significance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

The spectrum of mutations causing end-plate acetylcholinesterase deficiency

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Targeting acetylcholinesterase to the neuromuscular synapse

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6044427

10.1016/J.JNS.2014.12.015

13 August 2018

Identifiers

DOI

1 reference

18 July 2018

PMC publication ID

6044427

1 reference

18 July 2018

PubMed publication ID

25577314

1 reference

18 July 2018